Signal / Singapore / United Kingdom / Reading sale proceeds in a business budget

Thakral expects S$56.5m from a share sale. Has the cash arrived?

Thakral put net proceeds from a sale of Beauty Tech shares at about S$56.5 million. One line in the filing gives a conflicting price; the proceeds sections and the bookrunner support £5.05 per share. Cash settlement was expected on 23 November, not verified. The money is due to Thakral, not Beauty Tech. If a budget depends on it, wait for evidence of receipt and a separate spending decision.

Use this if

You read Singapore corporate disclosures or track whether a particular business project has confirmed funds.

No action if

Do not count expected cash as received. Do not infer a spending commitment, make a trade or use the block price as a price available to the public.

Article time zone:

Asia/Singapore

Who is outside the scope:

Business-accounting explanation only. No stock recommendation, valuation, account access, transaction or investment advice.

First published

Singapore

OTR Emerging Data

Singapore | Business accounting and cash

A sale price is not cash in the budget

The quoted value, the price for the whole block and the cash the seller expects to keep are three different numbers.

What the sources show

Thakral’s filing appeared on SGXNet on 19 November at 11:21:45 pm Singapore time. It reports an agreement to sell all 6,683,868 remaining Beauty Tech shares. The opening paragraph says £2.05 per share, but the filing’s proceeds sections, Thakral’s separate release and the bookrunner’s notice all say £5.05. That is the figure that matches about £33.8 million gross. The bookrunner expected cash settlement on 23 November. We did not verify that the cash arrived.

Disclosure is not settlement
  1. 19 Nov · 23:21:45 SGTSGX posts the disposal filing.
  2. 23 Nov · expectedBookrunner expects cash settlement.
The filing calls 18 November its Closing Date. Actual cash receipt was not verified.

The new connection

A quoted price is not what a seller necessarily receives for a large block. The quoted £5.56 in Thakral’s filing put the same holding at about £37.2 million. The reported block price was £5.05, about 9.2% below that quote. After estimated fees, Thakral put its net proceeds at about £33.2 million, or S$56.5 million. Beauty Tech gets none of that cash: the sale was of existing shares, not new company funding.

One block, three measures
  • Quoted value£5.56 per share; about £37.2m for the block
  • Agreed gross sale£5.05 per share; about £33.8m for the block
  • Estimated net to sellerAbout £33.2m after estimated fees
Same 6,683,868 shares. Sale price about 9.2% below the quote. Filing introduction gives a conflicting £2.05; three records support £5.05.
  1. Read the price for the same block
  2. Check when cash settles and who gets it
  3. Look separately for an approved use

A realistic next move

If you track Thakral’s ability to fund a project, record three separate facts: the agreed sale price, the date cash settlement is expected, and the proof that money arrived. On or after 23 November, look for dated confirmation. If none is public, keep the receipt unverified and check the next accounts. Require a separate approved budget before treating the proceeds as funding for any specific project.

Before counting the money
  1. Identify the recipientCash is due to Thakral, not Beauty Tech.
  2. Verify cash arrivedLook for dated confirmation or later accounts.
  3. Verify the useLook separately for a named and funded budget.
A proposed public-document check, not a report of a payment or budget approval.

No dated confirmation that cash arrived, no final fees or cash balance, and no funded project named. The filing labels 18 November its Closing Date, but the bookrunner separately states an expected cash settlement date of 23 November. No explanation or corrected filing was verified for the £2.05 discrepancy.

The connection

Three different numbers: quote, sale and net proceeds

Thakral disclosed the price and size of its agreed disposal on 19 November in Singapore. The bookrunner set out the expected cash-settlement date and identified who would not receive proceeds.

Observed

Thakral’s filing appeared on SGXNet on 19 November at 11:21:45 pm Singapore time. It reports an agreement to sell all 6,683,868 remaining Beauty Tech shares. The opening paragraph says £2.05 per share, but the filing’s proceeds sections, Thakral’s separate release and the bookrunner’s notice all say £5.05. That is the figure that matches about £33.8 million gross. The bookrunner expected cash settlement on 23 November. We did not verify that the cash arrived.

The connection

A quoted price is not what a seller necessarily receives for a large block. The quoted £5.56 in Thakral’s filing put the same holding at about £37.2 million. The reported block price was £5.05, about 9.2% below that quote. After estimated fees, Thakral put its net proceeds at about £33.2 million, or S$56.5 million. Beauty Tech gets none of that cash: the sale was of existing shares, not new company funding.

How the effect travels

This was a resale of existing shares to institutions. The price for the whole block can differ from the quoted price. Fees reduce what the selling owner expects to receive, and settlement is a separate step.

In October 2025 Thakral had agreed to sell 2,864,515 shares at the £2.71 IPO price. In May 2026 a separate sale by certain pre-IPO shareholders was priced in which Beauty Tech was also not due any proceeds. Neither is the comparison price used here; the relevant quote for the November block was £5.56.

The decision path

Track cash and the budget separately

1. Compare the same block

Read the £5.56 quote against the £5.05 sale price. Keep quoted value, gross proceeds and estimated net separate.

2. Identify who receives the cash

The bookrunner says Beauty Tech receives none. The selling owner is Thakral.

3. Wait for evidence of cash

Check dated confirmation on or after 23 November. If it is not available, keep cash receipt unverified.

4. Look for an approved use

Do not count the proceeds in a specific project budget unless the company confirms how much it allocated.

Thakral is Singapore-listed and the shares sold were in a London-listed UK company. GBP is the price currency; the SGD amounts are approximate equivalents reported by Thakral.

Optional research / Checks 1–10

What the sources support

Money flow

Expected proceeds belong to the selling shareholder; none go to Beauty Tech. No independently verified cash receipt.

Orders

No customer orders. The placing agreement covers existing shares.

Bottleneck

Do not confuse the quoted share price, the price for the block and money actually received.

Beneficiaries

Thakral stands to receive net proceeds if settlement occurs; no named downstream beneficiary is established.

Company finances

Thakral reports about S$56.5m net and an expected S$17.9m disposal gain over the June book value. Gain and proceeds are different measures.

Costs payback

Thakral estimates about £0.6m in costs. No final fee total, future return or project economics established.

Ownership

The block was approximately 6.1% of Beauty Tech. The bookrunner says Thakral would retain no ordinary shares after completion.

Hiring

No hiring linked to the proceeds was verified.

Government

No government spending evidence; SGX and the UK regulatory disclosure are publication channels.

Language

English-language Singapore and UK disclosures checked.

Optional research / Checks 11–20

What would change the reading

Behaviour

Institutional placements can differ from the screen quote; no evidence of public access to this placement.

Contradiction

Filing introduction says £2.05; later sections, separate issuer release and the bookrunner support £5.05. The bookrunner’s Nov 23 settlement expectation is separate from the filing’s Nov 18 Closing Date label.

Missing proof

No cleared amount, final fees or specific money allocated to a project.

Approval

No reader eligibility or approval to take part assumed. This is an information check only.

Alternatives

Thakral may hold proceeds in short-term instruments or use them for general requirements; no need to assume a project.

Geography

Singapore seller and UK investee; comparisons use GBP per share and clearly labelled approximate SGD equivalents.

History

October 2025 IPO £2.71; separate May 2026 placement by certain pre-IPO shareholders also yielded no cash to Beauty Tech.

Awareness

Public disclosure does not establish a price available to a reader or a valuation gap.

Countercase

Market quote versus block price does not establish causation. Net proceeds and booked gains are not the same, and neither proves new project spending.

Action clock

23 November 2026 is the bookrunner’s expected cash settlement date, not a confirmed payment clock or trade instruction.

Evidence & next review

Read the originals

SGXNet: disposal posting clock

Published 2026-11-19

SGXNet broadcast at 23:21:45 SGT on 19 November. Shows the disclosure time, not payment time.

Source record

Publisher: SGXNet / Thakral

Original language: English

published date precision: day

Source publication date 2026-11-19

Section 1 says £2.05 although the Singapore-dollar equivalent is about S$8.59. Sections 3.2 and 5.2 say £5.05, consistent with £33.8m gross for 6,683,868 shares. Section 2.3 gives the £5.56 quoted price and about £37.2m market value on the date called the Closing Date by Thakral. Section 5.2 does not confirm when cash cleared.

Source record

Publisher: Thakral

Original language: English

published date precision: day

Source publication date 2026-11-19

Separately supports £5.05, the number of shares and about S$56.5m net. The release is dated 19 November; SGX lists the press release at 23:23 SGT. No new funded business or bank receipt.

Source record

Publisher: Thakral

Original language: English

published date precision: day

Source publication date 2026-11-19

The placing agent reports 505p for 6,683,868 shares; it expects cash settlement on 23 November and says Beauty Tech receives none. This is not a confirmed receipt. Public participation was excluded.

Source record

Publisher: Berenberg via LSE RNS, reproduced by Halifax

Original language: English

published date precision: day

Source publication date 2026-11-19

An earlier placing by other pre-IPO sellers also sent no proceeds to Beauty Tech. Different sellers, block and circumstances; not a price predictor.

Source record

Publisher: Berenberg, published by The Beauty Tech Group

Original language: English

published date precision: day

Source publication date 2026-05-07

The earlier filing reports £2.71 IPO pricing and an agreement to sell 2,864,515 shares. Different event; the IPO price is not the basis of the November quote-to-block comparison.

Source record

Publisher: Thakral

Original language: English

published date precision: day

Source publication date 2025-10-06

No dated confirmation that cash arrived, no final fees or cash balance, and no funded project named. The filing labels 18 November its Closing Date, but the bookrunner separately states an expected cash settlement date of 23 November. No explanation or corrected filing was verified for the £2.05 discrepancy.

Consequences and economics

First-order consequence

The agreed block price and quantity were disclosed.

Second-order consequence

If settlement completes as expected, cash is payable to Thakral, not Beauty Tech.

Third-order consequence

Thakral may hold the funds or use them for operations and other needs; nothing earmarked was verified.

Fourth-order consequence

A named project only gains a funding signal when the company identifies its budget or actual use.

Fifth-order consequence

Check later cash-flow and spending records before linking the sale to any business expansion.

Observed costs and benefits

The same block was marked at about £37.2m on the £5.56 quote. At £5.05, the agreed gross value was about £33.8m. Thakral estimated £33.2m net, about S$56.5m. The 9.2% gap compares £5.05 with £5.56 per share, not with book value or one investor’s return.

Challenge and uncertainty

Disconfirming evidence

Reported settlement is still expected; documented failure to settle, a changed amount, or no named use would weaken any specific funding inference. One error in the document does not establish a second deal price.

What would confirm it

Look for the seller’s dated receipt disclosure or cash-flow disclosure, followed by a separately documented use of proceeds.

What would disprove it

A failed settlement or lower paid amount would disprove the assumed cash amount; holding the money for general purposes would not support a project-specific claim.

AI powered research